C
ABBV icon

Covestor’s AbbVie ABBV Stock Holding History

Covestor’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
407
+7
+2% +$1.51K 0.06% 344
2026
Q1 		$87K Sell
400
-525
-57% -$116K 0.06% 355
2025
Q4 		$212K Sell
925
-4
-0.4% -$911 0.11% 192
2025
Q3 		$216K Sell
929
-8
-0.9% -$1.63K 0.12% 185
2025
Q2 		$174K Sell
937
-26
-3% -$4.83K 0.1% 244
2025
Q1 		$202K Buy
963
+16
+2% +$3.11K 0.13% 156
2024
Q4 		$168K Sell
947
-420
-31% -$77.2K 0.11% 250
2024
Q3 		$270K Buy
1,367
+60
+5% +$11.2K 0.17% 79
2024
Q2 		$224K Sell
1,307
-40
-3% -$6.63K 0.14% 130
2024
Q1 		$245K Sell
1,347
-96
-7% -$16.5K 0.16% 97
2023
Q4 		$223K Buy
1,443
+35
+2% +$5.1K 0.15% 104
2023
Q3 		$210K Sell
1,408
-165
-10% -$24.2K 0.16% 94
2023
Q2 		$212K Sell
1,573
-116
-7% -$17K 0.16% 98
2023
Q1 		$269K Buy
1,689
+155
+10% +$23.7K 0.23% 50
2022
Q4 		$247K Buy
1,534
+755
+97% +$116K 0.2% 68
2022
Q3 		$104K Sell
779
-1,476
-65% -$212K 0.09% 331
2022
Q2 		$345K Buy
2,255
+517
+30% +$79K 0.27% 43
2022
Q1 		$282K Buy
1,738
+279
+19% +$40.5K 0.19% 72
2021
Q4 		$198K Buy
+1,459
New +$172K 0.28% 32

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Covestor's ABBV Position: Q2 2026 in Review

Covestor increased its AbbVie (ABBV) stake by 1.8% in Q2 2026, buying an estimated $1.51K and bringing the position to 407 shares worth $103K. The position accounts for 0.06% of the portfolio, ranked #344.

Covestor first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $345K in Q2 2022. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Covestor held 407 shares of AbbVie worth $103K as of Q2 2026.
  • Covestor bought 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.06% of Covestor's portfolio in Q2 2026, its #344 holding.
  • Covestor first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Covestor's AbbVie position peaked at $345K in Q2 2022.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.